Log in to save to my catalogue

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improve...

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improve...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2420136558

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

About this item

Full title

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

Publisher

United States: Wolters Kluwer

Journal title

The American journal of gastroenterology, 2020-07, Vol.115 (7), p.1055-1065

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer

More information

Scope and Contents

Contents

Nonalcoholic fatty liver disease (NAFLD) is an obesity-related disorder that is rapidly increasing in incidence and is considered the hepatic manifestation of the metabolic syndrome. The gut microbiome plays a role in metabolism and maintaining gut barrier integrity. Studies have found differences in the microbiota between NAFLD and healthy patient...

Alternative Titles

Full title

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2420136558

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2420136558

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/ajg.0000000000000661

How to access this item